Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasis Top-line data from the 12-week double-blind trial expected by year-end 2025 Phase 1b trial designe ...
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 dose Results from OVATION 2 Study continue to validate TheraPlas® ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
After a six-month pilot period that pitted five major ambient scribes against each other, Cleveland Clinic selected a ...
ca.investing.com on MSN22h
Moderna has limited upside: BarclaysBarclays downgraded Moderna (NASDAQ:MRNA) to Equal Weight from Overweight in a note Tuesday, citing policy risks, a lack of major clinical catalysts, and macroeconomic uncertainties that limit the ...
EQS-News: GeoVax, Inc. / Key word (s): Financial Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification 19.02.2025 / 15:04 CET/CEST The issuer is solely responsible for the ...
Layoffs, funding freezes, and executive orders spark outcry among federal researchers and university partners, fearing that ...
Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate ...
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving ...
With federal support, universities produce world-changing discoveries and the next generation of exquisitely well-trained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback